Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73621387)
Watch
English
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom
scientific article published on 01 January 1997
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
editorial
0 references
title
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
main subject
tamoxifen
1 reference
based on heuristic
inferred from title
author
Helena Earl
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
Richard Gray
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
author name string
D Kerr
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
M Lee
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
publication date
1 January 1997
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
published in
Clinical Oncology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
page(s)
141-143
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
cites work
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential role of tamoxifen in prevention of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of endometrial cancer after tamoxifen treatment of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endometriosis during tamoxifen treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0936-6555%2897%2980067-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0936-6555(97)80067-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
PubMed publication ID
9269542
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9269542
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9269542%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
